Stem's first quarter 2024 results showed a revenue decrease to $25.5 million due to a $33 million non-cash adjustment, but the company achieved a record non-GAAP gross margin and improved adjusted EBITDA year-over-year. They are accelerating the conversion of CARR-to-ARR and reaffirming full-year guidance for adjusted EBITDA and operating cash flow.
Revenue decreased to $25.5 million, impacted by a $33 million reduction due to updated contract guarantee valuations.
Non-GAAP gross margin increased to 24% from 19% in Q1 2023.
Bookings were $23.8 million, reflecting variability from large, utility-scale projects.
Contracted backlog was $1.6 billion, after efforts to upgrade profitability.
The company is updating its full year 2024 guidance ranges. They reaffirm full year 2024 revenue projected quarterly performance.
Analyze how earnings announcements historically affect stock price performance